CC
KROS icon

Centiva Capital’s Keros Therapeutics KROS Stock Holding History

Centiva Capital’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-90,000
Closed -$917K – 1479
2025
Q1 		$917K Buy
+90,000
New +$917K 0.03% 421